Intravenous Treatment in Nursing Homes
3IV
Can a Structured Training Program in Intravenous Treatment of Infections in Nursing Homes Lead to a Better Patient Trajectory and Reduced Hospital Admittance?
1 other identifier
interventional
330
1 country
1
Brief Summary
The primary objective for the project is to evaluate whether nursing home residents who require intravenous fluids and intravenous antibiotics, can be treated just as well or even better in the nursing home as in the hospital. In Vestfold, Norway, a structured training program in the intravenous treatment of dehydration and infections in nursing homes is planned. The 3IV study will evaluate if this leads to an equal or better patient trajectory and reduced hospital admittance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Nov 2009
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 1, 2009
CompletedFirst Posted
Study publicly available on registry
December 2, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedMay 13, 2016
May 1, 2016
3.1 years
December 1, 2009
May 12, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
All cause morbidity and mortality
Within 30 days after disease onset
Secondary Outcomes (3)
Number of admissions and days in hospitals among nursing home residents
Primarily within 30 days after disease onset
Patient trajectory
Primarily within 30 days after disease onset
Satisfaction in patients, next of kin and staff
Primarily within 30 days after disease onset
Study Arms (2)
Usual care
NO INTERVENTIONNursing home residents who require intravenous fluids and intravenous antibiotics was treated as usual (hospital admissions for intravenous treatment). In control nursing homes that had not completed the training program (intervention period), nursing home residents who require intravenous fluids and intravenous antibiotics was treated as usual. The majority of these patients were admitted to hospital for intravenous treatment. A few nursing homes or nursing home departments had sufficient expertise and capacity to provide treatment locally.
A training program in iv treatment
OTHERA structured training program in intravenous treatment in nursing homes: Each of 30 participating nursing homes sequentially received theory and practical training in intravenous treatment. In nursing homes that had completed the training program (intervention period), and had sufficient expertise and capacity, nursing home residents in need of intravenous fluids or antibiotics were treated locally; otherwise they were hospitalized.
Interventions
A structured training program in nursing homes in the intravenous treatment of dehydration and infections.
Eligibility Criteria
You may qualify if:
- Nursing home residents in need of intravenous fluids or antibiotics
You may not qualify if:
- Patients who needs hospitalization due to either co-morbidity or seriousness of disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Oslo
Oslo, Norway
Related Publications (2)
Klomstad K, Pedersen R, Forde R, Romoren M. Involvement in decisions about intravenous treatment for nursing home patients: nursing homes versus hospital wards. BMC Med Ethics. 2018 May 8;19(1):34. doi: 10.1186/s12910-018-0258-5.
PMID: 29739393DERIVEDNyborg G, Brekke M, Straand J, Gjelstad S, Romoren M. Potentially inappropriate medication use in nursing homes: an observational study using the NORGEP-NH criteria. BMC Geriatr. 2017 Sep 19;17(1):220. doi: 10.1186/s12877-017-0608-z.
PMID: 28927372DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 1, 2009
First Posted
December 2, 2009
Study Start
November 1, 2009
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
May 13, 2016
Record last verified: 2016-05
Data Sharing
- IPD Sharing
- Will not share